Bloodstream infections can develop late (after day 100) and/or in the absence of neutropenia in children receiving allogeneic bone marrow transplantation

V. Romano, E. Castagnola, S. Dallorso, E. Lanino, A. Calvi, S. Silvestro, G. Morreale, R. Giacchino, G. Dini

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

We retrospectively evaluated the incidence and time from transplantation of bloodstream infections occurring in children receiving bone marrow transplant (BMT) at G Gaslini Children's Hospital between September 1984 and December 1997. During this period the incidence was 35% after allogeneic and 26% after autologous BMT (P = 0.08). Among these episodes, 38% after allogeneic BMT and 90% after autologous BMT were detected in the presence of neutropenia within the first 30 days from reinfusion (P <0.001). Incidence of catheter-related bloodstream infections was 40% after allogeneic and 8% after autologous BMT (P <0.001). Bloodstream infections in the absence of neutropenia were 55% after allogeneic BMT vs 10% after autologous BMT (P <0.001) and occurred later after reinfusion (mean 199 vs 41 days, P <0.001). Among the episodes occurring after allogeneic BMT and in the absence of neutropenia, 61% were related to the presence of a central venous catheter, 15% were related to the presence of GVHD, but 23% were not associated with any of major risk factors for infection. Finally, 38% of episodes following allogeneic BMT were detected after day 100 vs 1% after autologous BMT. We concluded that patients receiving allogeneic BMT experience a high incidence of bloodstream infections in the absence of neutropenia and that a significant proportion of these episodes is not clearly associated with well known risk factors such as GVHD or central venous catheters. Moreover, many episodes develop a long time after the transplantation procedure. Therefore, any febrile episode following allogeneic BMT even late and/or in the absence of neutropenia should be intensively managed.

Original languageEnglish
Pages (from-to)271-275
Number of pages5
JournalBone Marrow Transplantation
Volume23
Issue number3
Publication statusPublished - 1999

Fingerprint

Homologous Transplantation
Neutropenia
Bone Marrow Transplantation
Bone Marrow
Transplants
Infection
Central Venous Catheters
Incidence
Transplantation
Catheter-Related Infections
Fever

Keywords

  • Bacteremia
  • Children
  • Late infections
  • Marrow transplant

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Bloodstream infections can develop late (after day 100) and/or in the absence of neutropenia in children receiving allogeneic bone marrow transplantation. / Romano, V.; Castagnola, E.; Dallorso, S.; Lanino, E.; Calvi, A.; Silvestro, S.; Morreale, G.; Giacchino, R.; Dini, G.

In: Bone Marrow Transplantation, Vol. 23, No. 3, 1999, p. 271-275.

Research output: Contribution to journalArticle

@article{808b68ff20154998bdbc24c141fc3e92,
title = "Bloodstream infections can develop late (after day 100) and/or in the absence of neutropenia in children receiving allogeneic bone marrow transplantation",
abstract = "We retrospectively evaluated the incidence and time from transplantation of bloodstream infections occurring in children receiving bone marrow transplant (BMT) at G Gaslini Children's Hospital between September 1984 and December 1997. During this period the incidence was 35{\%} after allogeneic and 26{\%} after autologous BMT (P = 0.08). Among these episodes, 38{\%} after allogeneic BMT and 90{\%} after autologous BMT were detected in the presence of neutropenia within the first 30 days from reinfusion (P <0.001). Incidence of catheter-related bloodstream infections was 40{\%} after allogeneic and 8{\%} after autologous BMT (P <0.001). Bloodstream infections in the absence of neutropenia were 55{\%} after allogeneic BMT vs 10{\%} after autologous BMT (P <0.001) and occurred later after reinfusion (mean 199 vs 41 days, P <0.001). Among the episodes occurring after allogeneic BMT and in the absence of neutropenia, 61{\%} were related to the presence of a central venous catheter, 15{\%} were related to the presence of GVHD, but 23{\%} were not associated with any of major risk factors for infection. Finally, 38{\%} of episodes following allogeneic BMT were detected after day 100 vs 1{\%} after autologous BMT. We concluded that patients receiving allogeneic BMT experience a high incidence of bloodstream infections in the absence of neutropenia and that a significant proportion of these episodes is not clearly associated with well known risk factors such as GVHD or central venous catheters. Moreover, many episodes develop a long time after the transplantation procedure. Therefore, any febrile episode following allogeneic BMT even late and/or in the absence of neutropenia should be intensively managed.",
keywords = "Bacteremia, Children, Late infections, Marrow transplant",
author = "V. Romano and E. Castagnola and S. Dallorso and E. Lanino and A. Calvi and S. Silvestro and G. Morreale and R. Giacchino and G. Dini",
year = "1999",
language = "English",
volume = "23",
pages = "271--275",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Bloodstream infections can develop late (after day 100) and/or in the absence of neutropenia in children receiving allogeneic bone marrow transplantation

AU - Romano, V.

AU - Castagnola, E.

AU - Dallorso, S.

AU - Lanino, E.

AU - Calvi, A.

AU - Silvestro, S.

AU - Morreale, G.

AU - Giacchino, R.

AU - Dini, G.

PY - 1999

Y1 - 1999

N2 - We retrospectively evaluated the incidence and time from transplantation of bloodstream infections occurring in children receiving bone marrow transplant (BMT) at G Gaslini Children's Hospital between September 1984 and December 1997. During this period the incidence was 35% after allogeneic and 26% after autologous BMT (P = 0.08). Among these episodes, 38% after allogeneic BMT and 90% after autologous BMT were detected in the presence of neutropenia within the first 30 days from reinfusion (P <0.001). Incidence of catheter-related bloodstream infections was 40% after allogeneic and 8% after autologous BMT (P <0.001). Bloodstream infections in the absence of neutropenia were 55% after allogeneic BMT vs 10% after autologous BMT (P <0.001) and occurred later after reinfusion (mean 199 vs 41 days, P <0.001). Among the episodes occurring after allogeneic BMT and in the absence of neutropenia, 61% were related to the presence of a central venous catheter, 15% were related to the presence of GVHD, but 23% were not associated with any of major risk factors for infection. Finally, 38% of episodes following allogeneic BMT were detected after day 100 vs 1% after autologous BMT. We concluded that patients receiving allogeneic BMT experience a high incidence of bloodstream infections in the absence of neutropenia and that a significant proportion of these episodes is not clearly associated with well known risk factors such as GVHD or central venous catheters. Moreover, many episodes develop a long time after the transplantation procedure. Therefore, any febrile episode following allogeneic BMT even late and/or in the absence of neutropenia should be intensively managed.

AB - We retrospectively evaluated the incidence and time from transplantation of bloodstream infections occurring in children receiving bone marrow transplant (BMT) at G Gaslini Children's Hospital between September 1984 and December 1997. During this period the incidence was 35% after allogeneic and 26% after autologous BMT (P = 0.08). Among these episodes, 38% after allogeneic BMT and 90% after autologous BMT were detected in the presence of neutropenia within the first 30 days from reinfusion (P <0.001). Incidence of catheter-related bloodstream infections was 40% after allogeneic and 8% after autologous BMT (P <0.001). Bloodstream infections in the absence of neutropenia were 55% after allogeneic BMT vs 10% after autologous BMT (P <0.001) and occurred later after reinfusion (mean 199 vs 41 days, P <0.001). Among the episodes occurring after allogeneic BMT and in the absence of neutropenia, 61% were related to the presence of a central venous catheter, 15% were related to the presence of GVHD, but 23% were not associated with any of major risk factors for infection. Finally, 38% of episodes following allogeneic BMT were detected after day 100 vs 1% after autologous BMT. We concluded that patients receiving allogeneic BMT experience a high incidence of bloodstream infections in the absence of neutropenia and that a significant proportion of these episodes is not clearly associated with well known risk factors such as GVHD or central venous catheters. Moreover, many episodes develop a long time after the transplantation procedure. Therefore, any febrile episode following allogeneic BMT even late and/or in the absence of neutropenia should be intensively managed.

KW - Bacteremia

KW - Children

KW - Late infections

KW - Marrow transplant

UR - http://www.scopus.com/inward/record.url?scp=0033022101&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033022101&partnerID=8YFLogxK

M3 - Article

C2 - 10084259

AN - SCOPUS:0033022101

VL - 23

SP - 271

EP - 275

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 3

ER -